Italy develops and studies Ebola vaccines

The journalist citing Nature's scientific journal, Italy, has initially researched and developed an Ebola virus vaccine.

>>>New hope in the fight against Ebola virus

Through monkey tests, the virus produced positive results within 10 months. The vaccine is produced by a group of US and Italian researchers at the IBRM Science Institute based in Pomezia, southern Rome.

Photo: clickondetroit

Currently, the phase of a human vaccine trial has been developed. This is one of the two vaccines that the World Health Organization supports to study against the deadly plague that is raging in West Africa.

According to the World Health Organization's assessment, West African Ebola disease has been considered the worst since 40 years ago. Since Ebola outbreaks so far, about 1,500 people out of 3,000 people infected with Ebola have died.

Earlier this September, Italian Health Minister Beatrice Lorenzin recently announced that the risk of spreading Ebola virus in Italian territory is very low. However, on September 9, the first case of Ebola infection was discovered in the Marche region, eastern North Italy.

The patient is believed to have symptoms of Ebola as a foreign woman, about 40 years old, living in the city of Civitanova Marche. Recently, this woman had time in Nigeria.

The title has been reset by repository.